News

VIDEO: What's next for lung cancer detection and treatment?


 

In an interview at the Joint Conference on the Molecular Origins of Lung Cancer, Dr. Roy Herbst, chief of medical oncology at the Yale Cancer Center in New Haven, Conn., offers his perspectives on new developments in lung cancer screening and treatment, and he discusses the promise that genetically targeted approaches and immunotherapy may offer.

Recommended Reading

High schoolers smoking more cigars, pipes, e-cigarettes
MDedge Hematology and Oncology
Radiological guidance does not improve tracheobronchial stent insertion
MDedge Hematology and Oncology
Electrocautery incision of lymph nodes improved biopsy yield
MDedge Hematology and Oncology
Afatinib superior to chemotherapy for EGFR-mutated NSCLC
MDedge Hematology and Oncology
Continued smoking after cancer diagnosis ups mortality risk
MDedge Hematology and Oncology
Smoking cessation agents don’t raise serious CVD risks
MDedge Hematology and Oncology
18% of lung cancers caught by CT screening were indolent
MDedge Hematology and Oncology
USPSTF gives final recommendation on lung cancer screening
MDedge Hematology and Oncology
Bupropion-varenicline combo gave harder kick to smoking habits
MDedge Hematology and Oncology
Pediatricians, cancer groups ask regulators to help cut tobacco use
MDedge Hematology and Oncology